DNLI Next Earnings Date Notes

— Denali Therapeutics (DNLI) is a biopharmaceutical company focused on discovering & developing therapies for neurodegenerative diseases, most notably Alzheimer’s, Parkinson’s, ALS, and other conditions involving the central nervous system. Leveraging its proprietary Transport Vehicle (TV) technology to enhance delivery of therapeutics across the blood-brain barrier, Denali has formed key partnerships, including with Biogen & Sanofi. As an investor preparing for DNLI’s next earnings call, jot down not only clinical milestones (e.g., clinical trial initiations, data readouts, & regulatory updates) but also cash runway & R&D spend, which are especially crucial for an R&D-driven company without commercial-stage products. Pay close attention to updates on lead programs such as DNL310 (for Hunter syndrome) & DNL151 (for Parkinson's disease), as advancement or setbacks here could have outsized impacts. Revenue from milestone & collaboration payments, pipeline progress, and cash position are all key metrics. Ultimately, an ongoing assessment of the robustness & advancement of Denali’s clinical pipeline, coupled with prudent capital management, will best inform the company's potential for long-term value creation. The next projected earnings date for DNLI is 11/5/2026 after close (stay tuned for a confirmed earnings date once announced).

DNLI Next Earnings Date FAQ

On this page we presented the DNLI Next Earnings Date information for Denali Therapeutics along with recent past earnings dates. For Q2 of 2026, DNLI reported earnings of -0.680/share, with the earnings report taking place on 8/6/2026. For Q1 of 2026, DNLI reported earnings of -0.690/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, DNLI reported earnings of -0.730/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, DNLI reported earnings of -0.740/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, DNLI reported earnings of -0.720/share, with the earnings report taking place on 8/11/2025. Based on these past earnings dates, the projected next earnings date for DNLI is 11/5/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Denali Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Denali Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Denali Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next DNLI earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up DNLI's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the DNLI next earnings date.